Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
01 1Interquim, SA
01 1Kyungbo Pharmaceutical Co., Ltd.
01 1Rasagiline tartrate
01 1Spain
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
Registrant Name : Kyungbo Pharmaceutical Co., Ltd.
Registration Date : 2020-05-04
Registration Number : Number 1673-33-ND
Manufacturer Name : Interquim, SA
Manufacturer Address : c/ Joan Buscalla, 10, 08173 Sant Cugat del Vallaes (Barcelona), Spain
A Rasagiline Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rasagiline Tartrate, including repackagers and relabelers. The FDA regulates Rasagiline Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rasagiline Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rasagiline Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rasagiline Tartrate supplier is an individual or a company that provides Rasagiline Tartrate active pharmaceutical ingredient (API) or Rasagiline Tartrate finished formulations upon request. The Rasagiline Tartrate suppliers may include Rasagiline Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Rasagiline Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rasagiline Tartrate Drug Master File in Korea (Rasagiline Tartrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rasagiline Tartrate. The MFDS reviews the Rasagiline Tartrate KDMF as part of the drug registration process and uses the information provided in the Rasagiline Tartrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rasagiline Tartrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rasagiline Tartrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rasagiline Tartrate suppliers with KDMF on PharmaCompass.
We have 1 companies offering Rasagiline Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
